West Pharmaceutical Services (NYSE:WST) Receives Daily News Impact Score of 0.18

Media stories about West Pharmaceutical Services (NYSE:WST) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. West Pharmaceutical Services earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned headlines about the medical instruments supplier an impact score of 46.6244722045413 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the news headlines that may have impacted Accern Sentiment’s rankings:

Several research analysts have weighed in on WST shares. Wells Fargo & Co upped their price target on West Pharmaceutical Services from $105.00 to $112.00 and gave the stock an “outperform” rating in a research note on Friday, October 27th. Zacks Investment Research downgraded West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Saturday, January 6th. Finally, Goldman Sachs Group initiated coverage on West Pharmaceutical Services in a research report on Wednesday, January 24th. They set a “neutral” rating and a $110.00 target price for the company. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $108.17.

West Pharmaceutical Services (NYSE WST) traded down $3.32 during midday trading on Thursday, hitting $91.72. The stock had a trading volume of 53,385 shares, compared to its average volume of 351,384. The company has a quick ratio of 1.87, a current ratio of 2.59 and a debt-to-equity ratio of 0.15. The company has a market cap of $6,905.52, a P/E ratio of 35.79, a P/E/G ratio of 1.97 and a beta of 1.04. West Pharmaceutical Services has a 52-week low of $77.97 and a 52-week high of $103.36.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, February 15th. The medical instruments supplier reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.63 by $0.01. The firm had revenue of $415.60 million during the quarter, compared to the consensus estimate of $416.90 million. West Pharmaceutical Services had a return on equity of 14.47% and a net margin of 12.12%. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.54 EPS. equities analysts expect that West Pharmaceutical Services will post 2.76 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Thursday, February 1st. Investors of record on Thursday, January 18th were given a $0.14 dividend. The ex-dividend date of this dividend was Wednesday, January 17th. This represents a $0.56 dividend on an annualized basis and a yield of 0.61%. West Pharmaceutical Services’s dividend payout ratio is presently 22.31%.

In related news, CFO William J. Federici sold 21,000 shares of the firm’s stock in a transaction on Friday, December 8th. The stock was sold at an average price of $99.01, for a total value of $2,079,210.00. Following the completion of the sale, the chief financial officer now directly owns 190,493 shares in the company, valued at $18,860,711.93. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.90% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “West Pharmaceutical Services (NYSE:WST) Receives Daily News Impact Score of 0.18” was published by Week Herald and is the sole property of of Week Herald. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://weekherald.com/2018/02/15/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-west-pharmaceutical-services-wst-share-price-2.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Insider Buying and Selling by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply